Policymaking through Adjudication: DEA’s Red Flags
DEA's red flags policy has made some pharmacies reluctant to fill prescriptions for buprenorphine, a drug that can help tackle the opioid crisis.
Improving regulatory policy
through research, education, and outreach.
Promotes best practices for regulatory analysis
Improves regulatory processes and institutions
Serves as a source for objective information
"The GW Regulatory Studies Center has done phenomenal work in cataloguing and analyzing reforms in regulatory policy...[it is] a national treasure."
Cass R. Sunstein
Robert Walmsley University Professor, Harvard
OIRA Administrator Under President Obama
Policymaking through Adjudication: DEA’s Red Flags
DEA's red flags policy has made some pharmacies reluctant to fill prescriptions for buprenorphine, a drug that can help tackle the opioid crisis.
A Vast and Discretionary Regime
Federal agencies have significant discretion to remove or alter regulatory barriers to methadone treatment.
Court Decision Extends the Period for Issuing Midnight Rules
A court decision found that agencies cannot withdraw a final rule that has appeared in the Federal Register for public inspection without notice and comment.
"Your input and expertise during the drafting of the Early Participation in Regulations Act of 2019 and SMART Act of 2019 was invaluable."
Joint Statement (PDF)
Senator Kyrsten Sinema (D-AZ)
Senator James Lankford (R-OK)
"The GW Regulatory Studies Center provided me with the analytical skills I needed, and gave me a sense of community as an international student."
— Ana Maria Zárate Moreno
"It is rare to find a situation where you have a community of scholars who are so accomplished all studying regulation in one place."
— Christopher Carrigan
"The GW Regulatory Studies Center gives students hands on experience that I craved when I was in school. Programs like this are simply invaluable."
— Shawne McGibbon